Myriad Genetics Inc. (MYGN)
8.91
0.03 (0.34%)
At close: Mar 31, 2025, 1:47 PM
Myriad Genetics Cash Flow Statement
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 | FY04 | FY03 | FY02 | FY01 | FY00 | FY99 | FY98 | FY97 | FY96 | FY95 |
Net Income | -263.3M | -112M | -27.2M | -223.7M | 4.6M | 4.6M | 131M | 21.8M | 125.3M | 80.2M | 176.22M | 147.14M | 112.15M | 100.71M | 152.3M | 84.61M | 47.84M | -34.96M | -38.19M | -39.98M | -40.62M | -24.82M | -13.99M | -7.17M | -8.72M | -10M | -9.8M | -9.2M | -5.9M |
Depreciation & Amortization | 61.9M | 52.7M | 62.8M | 71.4M | 73M | 73M | 54.4M | 48.3M | 26.7M | 25M | 13.82M | 8.89M | 9.07M | 7.22M | 7.08M | 9.45M | 8.78M | 7.54M | 6.86M | 6.09M | 5.77M | 5.28M | 4.5M | 3.73M | 3.28M | 3.2M | 3.3M | 2.5M | 1.6M |
Stock-Based Compensation | 40.7M | 38.1M | 36.3M | 24.3M | 33.5M | 33.5M | 27.1M | 29.9M | 31.6M | 45.7M | 27.07M | 26.61M | 26.27M | 25.09M | 22.78M | 25.68M | n/a | n/a | -231K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Working Capital | 28.7M | -84.8M | 118.4M | n/a | -28M | -28M | 5.7M | 9M | -200K | -2.4M | -18.32M | 11.6M | 10.86M | 53.04M | 22K | -2M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Non-Cash Items | 23.4M | 48.3M | -139.4M | 70.9M | -3.4M | -3.4M | -51.3M | 40.3M | 32.4M | 28.6M | 25.61M | 24.07M | -11.07M | -81.22M | 28.37M | 17.93M | 30.25M | 12.74M | 4.7M | 4.51M | 2.03M | 352K | 464.4K | 415.13K | 502.09K | 200K | 100K | 200K | 100K |
Deferred Income Tax | -600K | -31.9M | -34.7M | -54.5M | 13.1M | 13.1M | -23.7M | 2.5M | 15.7M | 1.7M | 7.46M | 8.18M | 34.19M | 40.41M | -28.05M | 506K | n/a | n/a | 243K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 27M | -101.5M | 120.4M | 30.2M | -37.1M | -37.1M | -21.6M | -36.6M | -65.4M | -40.7M | -59.97M | -41.02M | -28.76M | 38.54M | -27.4M | -54.14M | 16.86M | -11.18M | -1.41M | 6.08M | 1.94M | -27.34M | -7.28M | -744.51K | 22.1M | -7.5M | -600K | -100K | 5.6M |
Operating Cash Flow | -110.9M | -106.3M | 18.2M | -26.9M | 83.7M | 83.7M | 115.9M | 106.2M | 166.3M | 140.5M | 190.21M | 173.87M | 141.85M | 130.76M | 155.09M | 84.04M | 103.74M | -25.85M | -28.03M | -23.3M | -30.88M | -46.54M | -16.31M | -3.78M | 17.16M | -14.1M | -7M | -6.6M | 1.4M |
Capital Expenditures | -73.3M | -45.3M | -18M | -13.2M | -8.6M | -8.6M | -8.4M | -6.1M | -5M | -23.9M | -14.27M | -11.37M | -10.16M | -5.79M | n/a | -7.53M | -13.68M | -11.4M | -7.68M | -6.74M | -3.88M | -8.04M | -6.85M | -5.26M | -4.62M | -4M | -3.2M | -4.7M | -6.4M |
Acquisitions | n/a | -57.2M | 379.1M | n/a | -278.5M | -278.5M | 8.4M | -216.1M | -37M | -20.1M | -223.53M | -5M | -799K | -79.42M | n/a | 7.53M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 14.85K | n/a | n/a | 100K | n/a |
Purchase of Investments | n/a | -103.2M | -147.8M | n/a | -78.5M | -78.5M | -80.9M | -87.5M | -164.5M | -80.7M | -161.76M | -443.78M | -396.07M | -425.15M | -477.56M | -308.57M | -191.7M | -197.84M | -165.52M | -44.6M | -52.73M | -51.78M | -89.76M | -249.33M | -23.98M | -291.7M | -840.6M | -582.8M | -622.2M |
Sales Maturities Of Investments | 105.2M | 128.2M | 61.1M | n/a | 79.2M | 79.2M | 77.7M | 163.4M | 115.1M | 165.6M | 381.9M | 384.56M | 385.24M | 456.07M | 52.16M | 111.85M | 174.42M | 162.48M | 100.47M | 70.96M | 58.64M | 50.71M | 137.18M | 172.21M | 25M | 300.2M | 841.1M | 592.2M | 569.6M |
Other Investing Acitivies | n/a | n/a | n/a | 74.8M | n/a | n/a | -8.4M | n/a | n/a | n/a | n/a | n/a | -17.1M | -100K | 348.73M | -9.63M | -349K | 20K | -100K | -100K | -100K | -2.85M | -2.48M | -2.7M | -750K | n/a | n/a | -100K | n/a |
Investing Cash Flow | 31.9M | -77.5M | 274.4M | 61.6M | -286.4M | -286.4M | -11.6M | -146.3M | -91.4M | 40.9M | -17.67M | -75.59M | -38.89M | -54.39M | -76.67M | -206.34M | -31.3M | -46.74M | -72.83M | 19.52M | 1.93M | -11.96M | 38.09M | -85.08M | -4.34M | 4.5M | -2.7M | 4.7M | -59M |
Debt Repayment | 39.8M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | -3.9M | -50M | -50M | n/a | -31.6M | -162.6M | -210.7M | -287.7M | -146.27M | -128.47M | -200.49M | -71.39M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | -340M | -340M | n/a | -403M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -4.5M | -14.3M | -16M | 11.5M | 678.6M | 338.6M | 11.1M | 805.4M | 94.3M | 3.4M | 75.91M | 65.71M | 59.22M | 58.83M | n/a | -136.13M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -200K | -400K | -300K | -300K |
Financial Cash Flow | 152.9M | -8M | -150.6M | -1M | 182.3M | 182.3M | -95M | 71.8M | -68.3M | -177.3M | -211.8M | -80.56M | -69.25M | -116.6M | -49.09M | -51.92M | 21.87M | 117.45M | 149.92M | 2.47M | 51.33M | 59.04M | 3.35M | 68.58M | 37.98M | 400K | 200K | 4.3M | 58.9M |
Net Cash Flow | 74.5M | -192.4M | 141.4M | 70.5M | -17.7M | -17.7M | 8.5M | 33.9M | 4.4M | -700K | -39.25M | 17.72M | 33.67M | -40.16M | 29.33M | -174.22M | 94.3M | 44.86M | 49.06M | -1.32M | 22.38M | 536K | 25.13M | -20.28M | 50.81M | -9.2M | -24.1M | -13.2M | -11.9M |
Free Cash Flow | -184.2M | -151.6M | 200K | -40.1M | 75.1M | 75.1M | 107.5M | 100.1M | 161.3M | 116.6M | 175.94M | 162.49M | 131.69M | 124.97M | 155.09M | 76.52M | 90.06M | -37.25M | -35.71M | -30.04M | -34.76M | -54.58M | -23.16M | -9.03M | 12.55M | -18.1M | -10.2M | -11.3M | -5M |